Muhammad Ilyas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammad Ilyas has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Asif Mir
Department of Biological Sciences, International Islamic University, Islamabad, Pakistan
1 shared publication - Henry Houlden
UCL Queen Square Institute of Neurology and the National Hospital for Neurology and Neurosurgery
1 shared publication - Stephanie Efthymiou
Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK
1 shared publication
Latest Publications
- Open Access
- 16 January 2020
- Published by F1000 Research Ltd in F1000Research
- Vol. 9, 22
The genetics of intellectual disability: advancing technology and gene editing
Intellectual disability (ID) is a neurodevelopmental condition affecting 1–3% of the world’s population. Genetic factors play a key role causing the congenital limitations in intellectual functioning and adaptive behavior. The heterogeneity of ID makes it more challenging for genetic and clinical diagnosis, but the advent of large-scale genome sequencing projects in a trio approach has proven very effective. However, many variants are still difficult to interpret. A combined approach of next-generation sequencing and functional, electrophysiological, and bioinformatics analysis has identified new ways to understand the causes of ID and help to interpret novel ID-causing genes. This approach offers new targets for ID therapy and increases the efficiency of ID diagnosis. The most recent functional advancements and new gene editing techniques involving the use of CRISPR–Cas9 allow for targeted editing of DNA in in vitro and more effective mammalian and human tissue-derived disease models. The expansion of genomic analysis of ID patients in diverse and ancient populations can reveal rare novel disease-causing genes.
- 16 January 2020
- Published by F1000 Research Ltd in F1000Research
- Vol. 9, 22
Open AccessThe genetics of intellectual disability: advancing technology and gene editing
Intellectual disability (ID) is a neurodevelopmental condition affecting 1–3% of the world’s population. Genetic factors play a key role causing the congenital limitations in intellectual functioning and adaptive behavior. The heterogeneity of ID makes it more challenging for genetic and clinical diagnosis, but the advent of large-scale genome sequencing projects in a trio approach has proven very effective. However, many variants are still difficult to interpret. A combined approach of next-generation sequencing and functional, electrophysiological, and bioinformatics analysis has identified new ways to understand the causes of ID and help to interpret novel ID-causing genes. This approach offers new targets for ID therapy and increases the efficiency of ID diagnosis. The most recent functional advancements and new gene editing techniques involving the use of CRISPR–Cas9 allow for targeted editing of DNA in in vitro and more effective mammalian and human tissue-derived disease models. The expansion of genomic analysis of ID patients in diverse and ancient populations can reveal rare novel disease-causing genes.